NeuroTrials Research
NeuroTrials Research is a privately held, Atlanta-based independent CRO founded in 1997 that conducts Phase I-IV clinical trials in neurology, sleep disorders, psychiatry, vaccines, and women's health for unnamed large pharmaceutical and medical device sponsors, recruiting from a 25,000+ patient proprietary database.
- Company typePrivate
- Founded1997
- HeadquartersAtlanta, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What NeuroTrials Research does
NeuroTrials Research is an independent, privately held contract research organization (CRO) founded in 1997 and headquartered in Atlanta, Georgia. The company conducts Phase I-IV clinical trials across neurology and central nervous system disorders, sleep disorders, psychiatric conditions, vaccines, women's health, and consumer devices and products. It operates a single state-of-the-art facility featuring multiple exam rooms, a patient lounge, conference facilities, and a dedicated in-house sleep laboratory with eight private sleep rooms, supported by on-site diagnostic equipment including EKG/ECG, calibrated blood pressure and measurement devices, and temperature-controlled investigational drug storage (-20° and -70° freezers). The company is led by CEO and Medical Director Michael Lacey, M.D., with principal investigators Matthews Gwynn, M.D. and Caroline Mianulli, FNP-C, providing 100+ years of combined clinical research experience.
The business model is professional services revenue: pharmaceutical and medical device company sponsors fund Phase I-IV trials in exchange for regulatory-grade clinical data, while patient volunteers receive study-related care and investigational drug at no cost plus compensation for time and travel. NeuroTrials recruits from a proprietary database of 25,000+ patients with a stated greater than 70% repeat-participation rate, supported by integrated digital and social media marketing (4,500+ followers), traditional marketing, community outreach, and database search. The company has completed 225+ research studies involving 3,000+ volunteers across Atlanta, its metropolitan suburbs, and the Southeastern US, and works with central IRBs for expedited study approval. Customer concentration is high, as the company serves unnamed large enterprise pharma and device sponsors, with no named logos disclosed and no information on revenue, contract values, or pricing publicly available.
NeuroTrials Research firmographics
Firmographics- Name
- NeuroTrials Research
- Legal name
- Neurotrials Research, Inc.
- Website
- https://neurotrials.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NeuroTrials Research is a privately held, Atlanta-based independent CRO founded in 1997 that conducts Phase I-IV clinical trials in neurology, sleep disorders, psychiatry, vaccines, and women's health for unnamed large pharmaceutical and medical device sponsors, recruiting from a 25,000+ patient proprietary database.
- Ownership category
- akta.pro rank
NeuroTrials Research industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where NeuroTrials Research is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NeuroTrials Research business model
Business model- GTM type
- B2B
- Offering type
- Services
Revenue model
- Clinical Trial Contract Research Services: NeuroTrials Research generates revenue by conducting investigational drug and device clinical trials (Phase I-IV) for pharmaceutical and device company sponsors. The company aligns with some of the world's largest and renowned pharmaceutical and device companies to conduct clinical research studies, with sponsors funding the studies in exchange for regulatory-grade clinical data.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
NeuroTrials Research product offering
Product offeringCore offering
NeuroTrials Research is a multi-specialty contract research organization (CRO) that conducts Phase I-IV clinical trials for pharmaceutical and medical device company sponsors. The firm operates an in-house sleep lab with 8 dedicated rooms, temperature-controlled investigational drug storage, on-site EKG/ECG capabilities, and centralized IRB access. It recruits from a 25,000+ patient database in Atlanta and the Southeastern US to deliver regulatory-grade clinical data to sponsors.
Product overview
NeuroTrials Research is a multi-specialty clinical research center offering Phase I-IV clinical trial services. The company operates through its core clinical research platform, conducting trials across multiple therapeutic areas including neurology/CNS disorders, sleep disorders, psychiatric conditions, vaccines, women's health, and consumer devices/products. Their flagship facility includes an in-house sleep lab with 8 dedicated sleep rooms. Currently active clinical trials include studies for narcolepsy type 2, shiftwork disorder, and idiopathic hypersomnia. The company has conducted over 225 research studies with over 3,000 volunteers since its founding in 1997.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Services
- Neurology / Central Nervous System Research
- Sleep Disorders Research
- Psychiatric / Mental Health Research Clinical trials for psychiatric conditions including anxiety, bipolar disorder, depression, schizophrenia, binge eating, and other mental health disorders.
- In-House Sleep Lab
Companies that use NeuroTrials Research
Customer profileNamed customers2 records
Segments2 records
NeuroTrials Research technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
NeuroTrials Research partnerships and signals
Strategic signalScale indicators9 records
Recent moves2 records
Expansion highlights3 records
NeuroTrials Research competitors and assessment
Company assessmentDirect peers
- Biotrial: Biotrial is a CRO focused on early-phase CNS and clinical pharmacology trials with a dedicated sleep lab and Phase I unit in Europe. It is a comparable peer because the business model (specialty CRO with embedded sleep/CNS capability) overlaps directly with NeuroTrials' approach.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO with a strong CNS, neuroscience, and complex disease focus. It is highly relevant as a peer because it routinely runs Phase I-IV neurology and sleep studies for similar biopharma sponsors, but at meaningfully larger global scale.
- Medpace: Medpace is a mid-size full-service CRO covering Phase I-IV across multiple therapeutic areas including CNS. It is comparable in business model (sponsor-funded trial execution) and target customer (mid-to-large biopharma) but operates globally with several hundred investigators.
- Clinilabs: Clinilabs is a CRO specializing in CNS, sleep medicine, and early-phase clinical pharmacology research, with dedicated sleep labs in New York and other U.S. sites. It is the most direct comp to NeuroTrials because of the shared sleep-lab infrastructure and CNS therapeutic focus.
Emerging players
- CTI Clinical Trial & Consulting Services: CTI is a mid-size global CRO with strong specialty expertise in rare disease and CNS among other areas. It is an emerging/specialty peer competing for similar sponsor programs where therapeutic focus and operational flexibility matter more than full-service scale.
Broad incumbents
- IQVIA: IQVIA is the world's largest CRO with broad capabilities across all therapeutic areas and phases. It is relevant as an incumbent competitor that NeuroTrials competes against when sponsors choose a full-service partner over a specialized single-site operator.
- Charles River Laboratories: Charles River is a major CRO and research models provider spanning preclinical and clinical services. It is a broad incumbent that competes for sponsor R&D budgets that could otherwise flow to specialized sites like NeuroTrials.
- ICON plc: ICON is a top-tier global CRO following its PRA Health Sciences merger, offering full Phase I-IV services. It is a broad incumbent competitor whose CNS/sleep sponsors frequently overlap with NeuroTrials' target customer set.
- PPD (Thermo Fisher Scientific): PPD (now part of Thermo Fisher) is a large CRO providing comprehensive clinical development services. It competes with NeuroTrials in Phase II-IV CNS and sleep trial staffing and is a logical incumbent benchmark.
- Syneos Health: Syneos Health is a fully integrated CRO and contract commercial organization. It serves many of the same pharmaceutical and device sponsors NeuroTrials targets and represents a broad incumbent alternative when sponsors choose scaled partners.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
NeuroTrials Research social profiles
Digital presenceNeuroTrials Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeuroTrials Research leadership team
Management profileNumber of profiles
NeuroTrials Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeuroTrials Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeuroTrials Research
What does NeuroTrials Research do?
NeuroTrials Research is a multi-specialty contract research organization (CRO) that conducts Phase I-IV clinical trials for pharmaceutical and medical device company sponsors. The firm operates an in-house sleep lab with 8 dedicated rooms, temperature-controlled investigational drug storage, on-site EKG/ECG capabilities, and centralized IRB access. It recruits from a 25,000+ patient database in Atlanta and the Southeastern US to deliver regulatory-grade clinical data to sponsors.
Is NeuroTrials Research a public or private company?
NeuroTrials Research is a private company. It is currently operating.
When was NeuroTrials Research founded?
NeuroTrials Research was founded in 1997. It employs 11 to 50 people.
Where is NeuroTrials Research based?
NeuroTrials Research is headquartered in Atlanta, United States, in the North America region.
How does NeuroTrials Research make money?
One revenue line is on record: clinical Trial Contract Research Services.
Who are NeuroTrials Research's main competitors?
Direct peers on record are Biotrial, Worldwide Clinical Trials, Medpace and Clinilabs. CTI Clinical Trial & Consulting Services is listed as an emerging player. Broad incumbents are IQVIA, Charles River Laboratories, ICON plc, PPD (Thermo Fisher Scientific) and Syneos Health.
Does NeuroTrials Research have an API?
No public API is recorded for NeuroTrials Research.
What industry is NeuroTrials Research in?
NeuroTrials Research's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.